AI assistant
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2016
Feb 25, 2016
30339_dirs_2016-02-25_30af04b9-4705-42ae-bd21-9bcfb9bc73ee.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2016-02-23
Reporting Person: Bedwell Warwick (President, Pharma Pkgs Systems)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-02-23 | Common Stock | A | 4613.0000 | $59.6400 | Acquired | 38778.0820 | Direct |
| 2016-02-23 | Common Stock | M | 3680.0000 | $54.1400 | Acquired | 42458.0820 | Direct |
| 2016-02-23 | Common Stock | S | 3680.0000 | $58.8405 | Disposed | 38778.0820 | Direct |
| 2016-02-24 | Common Stock | M | 3616.0000 | $47.3400 | Acquired | 42394.0820 | Direct |
| 2016-02-24 | Common Stock | S | 3616.0000 | $59.2347 | Disposed | 38778.0820 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-02-23 | Stock Option (Right to Buy) | $54.1400 | M | 3680.0000 | Disposed | 2025-02-23 | Common Stock (3680.0000) | Direct |
| 2016-02-23 | Stock Option (Right to Buy) | $59.6400 | A | 13012.0000 | Acquired | 2026-02-23 | Common Stock (13012.0000) | Direct |
| 2016-02-24 | Stock Option (Right to Buy) | $47.3400 | M | 3616.0000 | Disposed | 2024-02-24 | Common Stock (3616.0000) | Direct |
Footnotes
F1: Shares represent the portion of the Performance Share Unit Award granted in 2013 that have vested for period 12.
F2: This was multiple transactions on the same date with prices in the range of $58.69 to $58.98. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.
F3: This was multiple transactions on the same date with prices in the range of $59.01 to $59.40. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.
F4: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.